Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start" with more than 3,500 healthcare ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, ...

The scan method has enabled the team, led by researchers at Newcastle University, UK, to see how air moves in and out of the ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

The yellow zone means that you have more COPD symptoms than usual. You should call your healthcare provider if symptoms do not improve after treatment. You may experience increased shortness of breath ...

The results of the present study, which is the first to demonstrate the effects of NAC on lung function, support a role for NAC as an anti-inflammatory agent in the treatment of COPD exacerbations.

30 in The BMJ. William B. Feldman, MD, MPH, from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily ...

By Dr. Chinta Sidharthan The researchers evaluated budesonide-glycopyrrolate-formoterol and ...

30 in The BMJ. William B. Feldman, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a ...